Amaero (3DA) Q4 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 TU earnings summary
23 Jul, 2026Executive summary
FY2026 revenue reached AUD 18.1 million, up 376% year-over-year, with record Q4 revenue of AUD 7.8 million, aligning with guidance and driven by new commercial agreements and expanded capacity.
Completed a three-year capital investment program, commissioning a third atomizer and scaling powder production capacity to 680 metric tons per year.
Entered FY2027 with a contracted backlog of AUD 23.1 million, including AUD 8.5 million in new contracts since June 30 and AUD 12.9 million scheduled for completion by December 2026.
Completed U.S. redomiciliation, PCAOB audit, and confidential SEC registration for a potential U.S. IPO, enhancing access to capital and eligibility for federal contracts.
Resolved operational incidents at the Tennessee facility with a comprehensive safety review and resumed production after a six-week pause.
Financial highlights
FY2026 revenue was AUD 18.1 million, with Q4 revenue of AUD 7.8 million, up 417% year-over-year; powder contributed 86% and PM-HIP 14% of full-year revenue.
Backlog at year-end was AUD 23.1 million, supporting revenue visibility, with 26 unique customers and both powder and PM-HIP contracts.
Cash position at June 30 was AUD 25.2 million, pro forma AUD 29.9 million after expected EXIM disbursement.
Capital investment of approximately AUD 80 million deployed over three years, completed on time and on budget.
Financing activities provided AUD 6.7 million net cash in Q4, with total available funding of AUD 24.8 million.
Outlook and guidance
Backlog provides revenue visibility into FY2027, with over 80% from long-term agreements and AUD 1.3 million in titanium powder orders deferred to Q1 FY2027.
Powder production capacity expected to increase to 920 metric tons in 2027, with argon gas recycler and fourth atomizer scheduled for commissioning in early and mid-2027.
FY2027 priorities include executing supply agreements, advancing customer qualifications, expanding submarine component qualifications, and progressing U.S. IPO plans.
No further financial guidance provided due to SEC registration process.
Latest events from Amaero
- Poised for rapid growth, Amaero leads U.S. advanced powder production and targets a U.S. IPO.3DA
IAccess Alpha Virtual Best Ideas Summer Investment Conference 202623 Jun 2026 - Shareholders and option holders strongly approved all proposed schemes and director option grants.3DA
Scheme Meeting 2026 presentation5 Jun 2026 - Q3 FY2026 revenue up 301%–347% YoY, FY2026 fully contracted, U.S. redomiciliation advances.3DA
Q3 2026 TU21 Apr 2026 - FY2025 saw record revenue, major supply deals, and facility expansion, setting up strong FY2026 growth.3DA
H2 202531 Mar 2026 - Strategic U.S. shift, capital raises, and C103 supply deals set path to EBITDA breakeven by FY2026.3DA
H2 202431 Mar 2026 - Revenue up 367%, net loss widens, FY2026 guidance cut amid U.S. contract delays.3DA
H1 202612 Feb 2026 - Transition to commercialization, capital raises, and U.S. expansion with new leadership.3DA
AGM 202418 Jan 2026 - Seven resolutions, including share placements and a name change, were presented and voted online.3DA
EGM 202524 Dec 2025 - Production and revenue scale rapidly with new atomizer, strong contracts, and U.S. market demand.3DA
Status Update12 Nov 2025